Claes-Ake Gullberg

Title: Claes-Ake Gullberg: Innovator in Hemodialysis Membrane Technology

Introduction

Claes-Ake Gullberg is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of hemodialysis through his innovative patents. With a total of two patents to his name, Gullberg's work focuses on the development of advanced membranes for medical applications.

Latest Patents

Gullberg's latest patents include a membrane and a process for producing the membrane. The first patent describes a membrane for hemodialysis that is prepared by casting, extruding, or spinning a solution of a polyether-polycarbonate block copolymer and a swelling agent. This membrane has a top cut-off value of less than about 68,000 Daltons, making it substantially impermeable to albumin while providing high permeability to water and other small molecules. The second patent involves a polyamide hollow fiber filtration membrane that has a barrier layer. This filtration membrane exhibits an ultrafiltration rate between 200×10^-4 and 500×10^-4 ml/sec.cm².bar at 20°C and is also substantially impermeable to albumin of a molecular weight of about 44,000 or greater.

Career Highlights

Throughout his career, Claes-Ake Gullberg has worked with prominent companies in the medical field, including Gambro Dialysatoren KG and Gambro Lundia AB. His experience in these organizations has contributed to his expertise in developing innovative solutions for hemodialysis.

Collaborations

Gullberg has collaborated with notable professionals in his field, including Hermann Josef Gohl and Georg B. Mayer. These collaborations have likely enriched his work and contributed to the advancements in membrane technology.

Conclusion

Claes-Ake Gullberg's contributions to hemodialysis membrane technology highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to enhancing patient care through advanced filtration solutions.